MedPath

Study of sentinel lymph node biopsy in early ovarian cancer

Not Applicable
Conditions
Health Condition 1: X- New Technology
Registration Number
CTRI/2022/07/044474
Lead Sponsor
APOORVA TAK
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Inclusion Criteria:

1.Age 18 and above.

2. Patients with a high likelihood of having a malignant ovarian tumor planned for exploratory laparotomy

3. Patients referred with confirmed ovarian tumor after previous surgery ( unilateral or bilateral salpingo-oophrectomy with or without hysterectomy) , those in whom the ovarian malignant tumour has already been resected and a second surgical procedure is planned to complete the staging procedure including lymph nodes.

Exclusion Criteria

Exclusion Criteria:

1. Previous vascular surgery of aorta,caval vein or iliac vessels

2. Previous lymphadenectomy or lymph node sampling in the iliac or paraortic region

3. History of malignant lymphoma

4. History of malignant tumor in abdominal cavity

•Previous allergic reaction to blue dye or human albumin

•Pregnant or lactating females

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath